IP Library Granted Patent US 9,101,684
Granted Patent B2
US 9,101,684 · App. 13/975,228 · Granted Aug 11, 2015

Coating formulations for scoring or cutting balloon catheters

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,101,684
App. No.
13/975,228
Granted
Aug 11, 2015
Kind
B2
Abstract

The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.

Claims (12)

1. A scoring or cutting angioplasty balloon catheter carrying at least on a portion of its surface a therapeutically effective amount of the oxidation-insensitive drug paclitaxel; an amount of the lipophilic antioxidant resveratrol that will protect the paclitaxel from premature loss during delivery to an angioplasty site and that is 3-100% by weight of the paclitaxel; and an amount of polymer that is 0-20% by weight of the paclitaxel.

2. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of resveratrol is 5-100% by weight of the weight of the paclitaxel.

3. A scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the resveratrol load is up to 10 g/mm 2 of coated catheter surface.

4. The scoring or cutting angioplasty balloon catheter according claim 1 , which has been polymer-free coated with paclitaxel and resveratrol both together dissolved in tetrahydrofuran or a mixture of solvents containing more than 25% (v/v) tetrahydrofuran or each separately dissolved optionally selecting a different solvent for the resveratrol.

5. The scoring or cutting angioplasty balloon catheter according to claim 1 , which has been polymer-free coated with paclitaxel and resveratrol both together dissolved in acetone or a mixture of solvents containing more than 25% (v/v) acetone or each separately dissolved optionally selecting a different solvent for the resveratrol.

6. The scoring or cutting angioplasty balloon catheter according to claim 1 , which has been polymer-free sequentially coated with paclitaxel and resveratrol in a way that the paclitaxel and the resveratrol are not homogeneously mixed.

7. The scoring or cutting angioplasty balloon catheter of claim 1 wherein the coating is polymer-free.

8. The scoring or cutting angioplasty balloon catheter of claim 1 wherein the catheter is a scoring balloon catheter.

9. The scoring or cutting angioplasty balloon catheter of claim 1 wherein the catheter is a cutting balloon catheter.

10. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of resveratrol is 10-100% by weight of the weight of the paclitaxel.

11. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of resveratrol is 20-100% by weight of the weight of the paclitaxel.

12. The scoring or cutting angioplasty balloon catheter according to claim 1 , wherein the amount of resveratrol is 50-100% by weight of the weight of the paclitaxel.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2024
From: KONINKLIJKE PHILIPS N.V.
To: INNORA HOLDING GMBH
Reel/Frame 066939/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2023
From: ANGIOSCORE LLC
To: SPECTRANETICS LLC
Reel/Frame 062627/0559 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: ANGIOSCORE INC.
Reel/Frame 037266/0474 →
SECURITY INTEREST (TERM) Recorded Dec 11, 2015
From: ANGIOSCORE INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037273/0804 →
SECURITY INTEREST (REVOLVER) Recorded Dec 11, 2015
From: ANGIOSCORE INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037273/0822 →
SECURITY INTEREST Recorded Jul 2, 2015
From: ANGIOSCORE INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 035973/0146 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2014
From: SPECK, ULRICH; BERG, MADELEINE C.
To: INNORA GMBH
Reel/Frame 032150/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2014
From: INNORA GMBH
To: ANGIOSCORE, INC.
Reel/Frame 032150/0106 →